✦ LIBER ✦
Interleukin-1 -regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study
✍ Scribed by Gul, A.; Tugal-Tutkun, I.; Dinarello, C. A.; Reznikov, L.; Esen, B. A.; Mirza, A.; Scannon, P.; Solinger, A.
- Book ID
- 126690693
- Publisher
- BMJ Publishing Group
- Year
- 2011
- Tongue
- English
- Weight
- 180 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0003-4967
No coin nor oath required. For personal study only.